Literature DB >> 18539232

Etiology of sarcoidosis.

Edward S Chen1, David R Moller.   

Abstract

Research over the past decade has advanced our understanding of the pathogenesis of sarcoidosis and provided new insights into potential causes of this disease. It is important to remember that any etiologic agent of sarcoidosis must be capable of causing the pathologic hallmark of systemic noncaseating granulomas and the heterogeneous clinical features of sarcoidosis. In addition, etiologic agents must be compatible with immunologic features, including polarized T-helper 1 cytokine profiles and oligoclonal T cell expansions consistent with antigen driven processes. Yet, even with studies conducted in this disease, there remains a lack of consensus on the etiology of sarcoidosis. This challenge is likely to be overcome only with additional research that incorporates clinical, genetic, immunologic, environmental, and microbiologic profiles in groups of patients, supplemented with testing of candidate pathogenic agents in experimental models that recapitulate critical features of this disease.

Entities:  

Mesh:

Year:  2008        PMID: 18539232     DOI: 10.1016/j.ccm.2008.03.011

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  44 in total

1.  The functional SLC11A1 gene polymorphisms are associated with sarcoidosis in Turkish population.

Authors:  Pinar Akçakaya; Benura Azeroglu; Ipek Even; Omer Ates; Hatice Turker; Gul Ongen; Aysegul Topal-Sarikaya
Journal:  Mol Biol Rep       Date:  2011-12-08       Impact factor: 2.316

2.  T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Authors:  Edward S Chen; Jan Wahlström; Zhimin Song; Matthew H Willett; Maria Wikén; Rex C Yung; Erin E West; John F McDyer; Ying Zhang; Anders Eklund; Johan Grunewald; David R Moller
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

3.  Co-occurrence of rheumatoid arthritis and sarcoidosis.

Authors:  Şenol Kobak; Ahmet Adnan Karaarslan; Hatice Yilmaz; Fidan Sever
Journal:  BMJ Case Rep       Date:  2015-07-06

4.  Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976-2013.

Authors:  P Ungprasert; C S Crowson; E L Matteson
Journal:  Osteoporos Int       Date:  2017-02-16       Impact factor: 4.507

Review 5.  Evidence for mycobacteria in sarcoidosis.

Authors:  Isaac Brownell; Francisco Ramírez-Valle; Miguel Sanchez; Stephen Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-09       Impact factor: 6.914

6.  Epidemiology of cutaneous sarcoidosis, 1976-2013: a population-based study from Olmsted County, Minnesota.

Authors:  P Ungprasert; D A Wetter; C S Crowson; E L Matteson
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-06-21       Impact factor: 6.166

Review 7.  Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota.

Authors:  P Ungprasert; C S Crowson; E L Matteson
Journal:  Reumatismo       Date:  2017-05-22

8.  PPAR-gamma pathways attenuate pulmonary granuloma formation in a carbon nanotube induced murine model of sarcoidosis.

Authors:  Matthew McPeek; Anagha Malur; Debra A Tokarz; Gina Murray; Barbara P Barna; Mary Jane Thomassen
Journal:  Biochem Biophys Res Commun       Date:  2018-06-15       Impact factor: 3.575

9.  Diagnostic criteria of tuberculous sarcoidosis.

Authors:  J R Shah; Jagruti Hede; R S Mathur
Journal:  Lung India       Date:  2009-07

10.  ApoE-deficient mice on cholate-containing high-fat diet reveal a pathology similar to lung sarcoidosis.

Authors:  Andriy O Samokhin; Frank Bühling; Franz Theissig; Dieter Brömme
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.